Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score
Cong Feng, Yinbin Zhang, Fei Wu, et al.
The Breast (2023) Vol. 69, pp. 392-400
Open Access | Times Cited: 9

Showing 9 citing articles:

DNA damage response in breast cancer and its significant role in guiding novel precise therapies
Jiayi Li, Ziqi Jia, Dong Lin, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer
Risav Banerjee, Indrajit Maitra, T. Bhattacharya, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104417-104417
Closed Access | Times Cited: 6
Characterization of Immune Landscape Based on Homologous Recombination Deficiency Associated Signatures and Identification of Knockdown of ERCC6L to Promote Radiosensitivity in Breast Cancer
Jiahao Li, Gong Chen, Haiting Zhou, et al.
The Journal of Gene Medicine (2025) Vol. 27, Iss. 2
Closed Access
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?
Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
International Journal of Cancer (2025)
Open Access
Multimodal deep learning model for predicting homologous recombination deficiency in prostate cancer: an international multi-cohort study
Zijian Song, Qianwen Zhang, Wenhui Zhang, et al.
Research Square (Research Square) (2025)
Closed Access
Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer
Zheng Wang, Yujie Lu, Mengyuan Han, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 2, pp. 429-440
Open Access | Times Cited: 2
Indirect targeting of MYC and direct targeting in combination with chemotherapies are more effective than direct mono-targeting in triple negative breast cancer
Negesse Mekonnen, Hobin Yang, Nirmal Rajasekaran, et al.
Translational Oncology (2024) Vol. 51, pp. 102204-102204
Open Access | Times Cited: 1
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing
M.A. Rezqallah Aron, Sara Torres‐Esquius, Alba Llop‐Guevara, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Establishment and verification of a nomogram to predict risk and prognostic factors of triple-negative breast cancer with organ metastasis based on the SEER cohort study
Yingjie Niu, Qiu‐Yun Chen, Yi Ni, et al.
Research Square (Research Square) (2023)
Open Access
Associaction between Prognosis, Carboplatin Treatmene Response and Homologous Recombination Deficiency Status in Early Triple-Negative Breast Cancer
Zheng Wang, Yujie Lu, Mengyuan Han, et al.
(2023)
Closed Access
Page 1

Scroll to top